Trial intelligence / Profile preview

Postpartum Management of Gestational Hypertensive Disorders Using Furosemide

NCT04343235Phase 4Terminated

Sponsor
Wright State University
Start
May 2020
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of furosemide in gestational hypertension (GH), preeclampsia, sponsored by Wright State University. Started May 2020; status: terminated.

02

Drugs

furosemide
03

Conditions

gestational hypertension (GH)preeclampsia

Beyond the preview

Go deeper on NCT04343235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04343235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call